1 recruiting. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Recruiting 1 |
Follow Follicular Lymphoma (FL) Grade 3B: new trials by email Literature Review of Follicular Lymphoma (FL) Grade 3B trials Research Report on Follicular Lymphoma (FL) Grade 3B
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Combining Loncastuximab Tesirine and Epcoritamab in Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL) Loncastuximab Tesirine and Epcoritamab - Aggressive Diffuse Large B-cell Lymphoma, High-grade B-cell Lymphoma (HGBL) | Phase 2 | Recruiting | Universität Münster | 120 | 2025-10-31 | 2026-07-30 |
Lymphoma, Follicular (1) · Lymphoma, Large B-Cell, Diffuse (1)
Hemic and Lymphatic Diseases (1) · Immune System Diseases (1) · Immunoproliferative Disorders (1) · Lymphatic Diseases (1) · Lymphoma (1) · Lymphoma, B-Cell (1) · Lymphoma, Non-Hodgkin (1) · Lymphoproliferative Disorders (1) · Neoplasms (1) · Neoplasms by Histologic Type (1)
Germany (1)
2023 (1)